Erandamooladi Basti along with Ayurvedic Multi Drug Therapy in the Treatment of Chronic Kidney Disease
- Conditions
- Health Condition 1: N183- Chronic kidney disease, stage 3 (moderate)Health Condition 2: N183- Chronic kidney disease, stage 3 (moderate)Health Condition 3: N189- Chronic kidney disease, unspecified
- Registration Number
- CTRI/2021/01/030193
- Lead Sponsor
- IPGT and RA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Patients having signs and symptoms of chronic kidney disease.
2.Patients of both genders between 18-60yrs of age.
3.Patients willing and able to participate.
4.Patients with serum creatinine level between1.2- 6 mg/dl will be included in the study.
5.Patients with serum urea level with in 120mg/dl
6.Patients who are yogya for basti karma.
1.Female patients having pregnancy, breast feeding or post-delivery period.
2.Patients of end stage renal failure.
3.Patients who are on dialysis treatment for more than 1-month period.
4.Patients who are already operated for renal transplantation and then having nephropathy.
5.Patients of hepato-renal insufficiency or renal insufficiency due to hemodynamic circulatory disorders and CCF.
6.Patients having some serious illness like cardio-vascular diseases, acute mental disorders, serious acute organic diseases, serious chronic co-morbidity, hypo or hyper thyroidism.
7.Patients having haemoglobin concentration below 8gm.
8.Having uncontrolled Hypertension(systolic <180mm/Hg, diastolic <100mm/Hg) and Diabetes mellitus (FBS- <200mg/dl)
9.Patients with serum urea level above 120mg/dl
10.Patients having symptoms of Uremia.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in serum creatinine and increase in eGFRTimepoint: After 4 weeks
- Secondary Outcome Measures
Name Time Method Reduction in signs and symptoms of CKDTimepoint: After 4 week